New insights into breast and endometrial cancers

Research output: Contribution to journalEditorialpeer-review

Abstract

Cancers of the breast and endometrium are some of the most common cancers affecting women. These cancers show estrogen-dependent proliferation in several cases; therefore, hormone therapeutic strategies are employed. Tamoxifen is an effective hormone therapy that is traditionally used for estrogen receptor-positive breast cancer patients. However, in endometrial cancer, tamoxifen treatment increases the risk of a poor prognosis type of endometrial cancer.

Original languageEnglish
Article number2595
Pages (from-to)1-6
Number of pages6
JournalCancers
Volume12
Issue number9
DOIs
Publication statusPublished - 2020 Sep

Keywords

  • Breast cancer
  • Endometrial cancer
  • Hormone
  • Prognostic factor
  • Therapeutic target molecule

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'New insights into breast and endometrial cancers'. Together they form a unique fingerprint.

Cite this